NCT01898403View on ClinicalTrials.gov

Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

April 30, 2015

Conditions
Recurrent Melanoma
Interventions
DRUG

Indocyanine green solution

Administered peri-tumoral and intradermally

DRUG

Isosulfan blue (ISB)

Administered peri-tumoral and intradermally

DIAGNOSTIC_TEST

Lymphoscintigraphy with 99-technetium (99Tc) sulfur colloid (TSC)

Trial Locations (1)

94305

Stanford University Hospitals and Clinics, Stanford

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Stanford University

OTHER

NCT01898403 - Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma | Biotech Hunter | Biotech Hunter